Most fenbendazole never reaches tumours — poor absorption is the #1 problem. This 2026 deep-dive covers exactly how fat increases bioavailability 1.6–2.8x, the science behind Vitamin E succinate, curcumin, berberine and CBD, cancer-type evidence for colorectal (strongest), lung, and prostate, a 3-benzimidazole comparison table, and 3-on-4-off vs daily dosing compared.

Fenbendazole has real preclinical anti-cancer evidence — but zero completed human RCTs as of July 2026 and documented liver injury cases. This complete guide covers the Joe Tippens pembrolizumab confound, Korean n=78 study, 2 Phase I registered trials, the tubulin and glucose mechanism, a full 9-row evidence table, and what patients must tell their oncologist before using it.

2025 has been a landmark year for cancer research. From an AI model predicting immunotherapy response from a routine blood test to personalised mRNA cancer vaccines reducing recurrence risk by 44 percent — here are the 7 biggest verified breakthroughs of the year, what they mean, and what they could mean for patients.

Cancer immunotherapy has transformed oncology more profoundly than any development since chemotherapy — turning once-fatal metastatic melanoma into a survivable disease for some patients. This plain-language guide explains how checkpoint inhibitors, CAR-T cell therapy, cancer vaccines, and monoclonal antibodies work and which cancers they treat.

Drug repurposing is one of the most active areas of modern oncology — investigating existing medicines for potential anti-cancer properties. This evidence-based guide covers proven successes like Thalidomide for multiple myeloma, current frontrunners like Metformin, and the critical distinction between laboratory findings and clinical proof that every patient should understand.

A dog deworming drug sparking global cancer treatment conversations — is fenbendazole the breakthrough patients are hoping for, or dangerous misinformation? This evidence-based guide covers the latest 2026 research, real risks, and what cancer patients in India need to know before considering it.